Related Experiment Videos
Localization of factor IXa and factor VIIIa interactive sites
L M O'Brien1, L V Medved, P J Fay
1Department of Medicine, University of Rochester School of Medicine and Dentistry, New York 14642, USA.
The Journal of Biological Chemistry
|November 10, 1995
Summary
The serine protease domain and light chain of factor IXa (activated blood coagulation factor X) are crucial for stabilizing its cofactor, factor VIIIa. These domains mediate interactions within the enzyme-cofactor complex.
Area of Science:
- Biochemistry
- Molecular Biology
- Hematology
Background:
- Factor IXa is a key enzyme in the blood coagulation cascade.
- Factor VIIIa acts as a cofactor, significantly enhancing factor IXa's activity.
- Understanding their interaction is vital for hemostasis and thrombosis research.
Purpose of the Study:
- To elucidate the specific contributions of factor IXa's domains to factor VIIIa interaction.
- To identify the binding sites for factor VIIIa subunits on factor IXa.
- To investigate the role of the serine protease domain in cofactor stabilization.
Main Methods:
- Proteolytic fragmentation of factor IXa.
- Selective thermal denaturation of the serine protease domain.
- Chemical modification of factor IXa (DEGR-IXa and Fl-FFR-IXa).
- Fluorescence anisotropy measurements to assess binding interactions.
Main Results:
- Factor IXa fragments lacking the serine protease domain could not enhance factor VIIIa reconstitution but inhibited it.
- Denaturation or modification of the serine protease domain affected factor VIIIa reconstitution.
- The factor IXa light chain (gamma-carboxyglutamic acid and EGF domains) interacts with the A1/A3-C1-C2 dimer.
- The serine protease domain interacts with the A2 subunit of factor VIIIa.
Conclusions:
- Both the serine protease domain and light chain of factor IXa are essential for stabilizing factor VIIIa.
- Distinct sites on factor IXa bind different subunits of its cofactor, factor VIIIa.
- These findings support a model of multiple interaction sites within the factor IXa-factor VIIIa complex.